Impaired asset

Franklin Covey Reports Second Quarter Fiscal 2024 Financial Results

Retrieved on: 
Wednesday, March 27, 2024

Net income for the second quarter was $0.9 million, or $0.06 per diluted share, compared with $1.7 million, or $0.12 per diluted share, in the second quarter of fiscal 2023.

Key Points: 
  • Net income for the second quarter was $0.9 million, or $0.06 per diluted share, compared with $1.7 million, or $0.12 per diluted share, in the second quarter of fiscal 2023.
  • Adjusted EBITDA for the second quarter of fiscal 2024 was slightly better than expected at $7.4 million compared with $8.2 million in fiscal 2023.
  • Operating Income: As a result of the factors noted above, the Company’s income from operations for the second quarter of fiscal 2024 was $1.4 million, compared with $2.8 million in the second quarter of fiscal 2023.
  • On Wednesday, March 27, 2024, at 5:00 p.m. Eastern (3:00 p.m. Mountain) Franklin Covey will host a conference call to review its fiscal 2024 second quarter financial results.

CenterPoint Energy Reports Strong Q3 Results, Raises Full Year 2023 Guidance and Capital Plan, and Initiates 2024 Guidance

Retrieved on: 
Thursday, October 26, 2023

Non-GAAP EPS for the third quarter 2023 was also $0.40, a 25% increase to the comparable quarter of 2022.

Key Points: 
  • Non-GAAP EPS for the third quarter 2023 was also $0.40, a 25% increase to the comparable quarter of 2022.
  • This will include approximately $200 million in 2023 and approximately $300 million in 2024 and 2025.
  • 2022 and 2023 non-GAAP EPS; 2023 and 2024 non-GAAP EPS guidance range
    Beginning in 2022, CenterPoint no longer separated utility and midstream operations and reported on a consolidated non-GAAP EPS basis.
  • To the extent actual results deviate from these assumptions, the 2023 and/or 2024 non-GAAP EPS guidance ranges may not be met, or the projected annual non-GAAP EPS growth rate may change.

LightInTheBox Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Monday, March 20, 2023

Total cost of revenues was $72.0 million in the fourth quarter of 2022, compared with $59.8 million in the same quarter of 2021.

Key Points: 
  • Total cost of revenues was $72.0 million in the fourth quarter of 2022, compared with $59.8 million in the same quarter of 2021.
  • Gross profit in the fourth quarter of 2022 was $84.4 million, compared with $53.4 million in the same quarter of 2021.
  • Gross margin was 53.9% in the fourth quarter of 2022, compared with 47.2% in the same quarter of 2021.
  • Included in G&A expenses, R&D expenses in the fourth quarter of 2022 were $5.3 million, compared with $4.9 million in the same quarter of 2021 and $4.8 million in the third quarter of 2022.

STEALTHGAS INC. Reports Fourth Quarter and an All Time Record Twelve Months 2022 Financial and Operating Results

Retrieved on: 
Tuesday, February 21, 2023

Drydocking costs for the three months ended December 31, 2022 and 2021, were $0.6 million and $0.9 million, respectively.

Key Points: 
  • Drydocking costs for the three months ended December 31, 2022 and 2021, were $0.6 million and $0.9 million, respectively.
  • Interest and finance costs for the three months ended December 31, 2022 and 2021 were $3.4 million and $3.1 million, respectively.
  • Interest income for the three months ended December 31, 2022 and 2021 was $0.7 million and $0.02 million, respectively.
  • The increase is mainly attributed to short-term investments of $51.5 million during the three months ended December 31, 2022.

Cresco Labs Announces First Quarter 2022 Results

Retrieved on: 
Wednesday, May 18, 2022

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), a vertically integrated, multi-state operator and the number one U.S. wholesaler of branded cannabis products, today released its financial results for the three months ended March 31, 2022.

Key Points: 
  • Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), a vertically integrated, multi-state operator and the number one U.S. wholesaler of branded cannabis products, today released its financial results for the three months ended March 31, 2022.
  • "Q1 was a solid quarter for the Cresco Labs team in a challenging environment for all consumer product categories.
  • We are pairing the best consumer brands with a broad, deep and strategic footprint, said Charles Bachtell, Co-Founder and CEO of Cresco Labs.
  • The compliance-focused foundation of both Cresco Labs and Columbia Care is helping ensure a smooth progression towards deal approval through a reasonable and manageable regulatory process.

Zhangmen Education Inc. Reports Fourth Quarter and Full Year 2021 Unaudited Financial Results

Retrieved on: 
Wednesday, March 30, 2022

SHANGHAI, March 30, 2022 /PRNewswire/ -- Zhangmen Education Inc. ("Zhangmen" or the "Company") (NYSE: ZME), a leading online education company in China, today announced its unaudited and unreviewed financial results for the fourth quarter and full year ended December 31, 2021.

Key Points: 
  • SHANGHAI, March 30, 2022 /PRNewswire/ -- Zhangmen Education Inc. ("Zhangmen" or the "Company") (NYSE: ZME), a leading online education company in China, today announced its unaudited and unreviewed financial results for the fourth quarter and full year ended December 31, 2021.
  • Gross margin in the fourth quarter of 2021 was 40.6%,compared with 44.0% in the same period of 2020.
  • Net income in the fourth quarter of 2021 was RMB146.3 million (US$23.0 million), compared with net loss of RMB599.9 million in the same period of 2020.
  • Zhangmen Education Inc. (NYSE: ZME) is a leading online education company in China providing quality-oriented education to students and on-campus education services to educational institutions.

Cresco Labs Announces Third Quarter 2021 Financial Results

Retrieved on: 
Thursday, November 11, 2021

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), a vertically integrated, multi-state operator and the number one U.S. wholesaler of branded cannabis products, today announced its financial results for the third quarter ended September 30, 2021.

Key Points: 
  • Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), a vertically integrated, multi-state operator and the number one U.S. wholesaler of branded cannabis products, today announced its financial results for the third quarter ended September 30, 2021.
  • 1 Note that the quarterly review process is still underway until financial results have been filed on SEDAR and EDGAR, and accordingly final results could change.
  • Cresco Labs references certain non-GAAP financial measures throughout this press release, which may not be comparable to similar measures presented by other issuers.
  • No assurances are given as to the future trading price or trading volumes of Cresco Labs shares, nor as to the Companys financial performance in future financial periods.

Facedrive Reports 2020 Financial Results and Provides Update

Retrieved on: 
Saturday, May 1, 2021

As a result, sales and marketing expense in Q2 2020 should have been lower by $2,700,000 and net loss also lower by $2,700,000.

Key Points: 
  • As a result, sales and marketing expense in Q2 2020 should have been lower by $2,700,000 and net loss also lower by $2,700,000.
  • This impairment charge represented approximately two-thirds of the book value of these intangible assets, reducing the book value to $169,506 as at December 31, 2020 (see Note 22 in the Company\xe2\x80\x99s audited annual financial statements for the year ended December 31, 2020).
  • As the indicators were present during the quarter ended September 30, 2020, the impairment charge should have been recorded in Q3 2020.
  • As a result, impairment of intangible assets in Q3 2020 should have been higher by $350,000 and net loss also increased by $350,000.

Kentucky First Federal Bancorp Releases Fiscal Year Results

Retrieved on: 
Monday, September 21, 2020

This compares to net income of $300,000 or $0.04 per common share for the quarter ended June 30, 2019.

Key Points: 
  • This compares to net income of $300,000 or $0.04 per common share for the quarter ended June 30, 2019.
  • The impairment charge represents an accounting transaction which had no impact on cash flows, liquidity, or key capital ratios of the Company or its bank subsidiaries.
  • Based on this analysis, the estimated fair value of the Company was less than book value, resulting in the $13.6 million goodwill impairment charge.
  • The Company sells its long-term fixed rate loans to the Federal Home Loan Bank of Cincinnati as part of its asset/liability management strategy.

Macy’s, Inc. Provides Preliminary First Quarter 2020 Sales and Operating Performance

Retrieved on: 
Thursday, May 21, 2020

(1) Operating Income / (Loss) excludes estimated pre-tax non-cash goodwill and long-lived asset impairment charges expected to be recorded for the first quarter of 2020.

Key Points: 
  • (1) Operating Income / (Loss) excludes estimated pre-tax non-cash goodwill and long-lived asset impairment charges expected to be recorded for the first quarter of 2020.
  • Looking back, our performance in February was solid and in line with our expectations, but we saw a precipitous decline in sales with the stores closure in March.
  • The digital performance was driven by strong execution and enhanced fulfillment options, including curbside pickup where allowed.
  • Macys, Inc. (NYSE: M) is one of the nations premier omni-channel fashion retailers, with fiscal 2019 sales of $24.6 billion.